UNSPSC 51284704: Midecamycin

This classification denotes a leucomycin and macrolides with the molecular formula C41H67NO15, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N34Z0Y5UH7, chemically known as leucomycin v, 3,4b-dipropanoate but generally known as midecamycin, which bears US NIH Compound Identifier 5382853. European Medicines Agency schedules midecamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08951MIG. The term MIDECAMYCIN is an International Non-Proprietary Name or INN.

Most nations schedule midecamycin under HS 29419000 and SITC 54139. As of Q4 2014, MIDECAMYCIN remains the US FDA Preferred Term for this commodity. SMILES: CCC(=O)OC1CC(=O)OC(CC=CC=CC(C(CC(C(C1OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C.

UNSPSC 51284704 Midecamycin is a Commodity code, but recent state and local solicitations tagged with this code are actually procuring naloxone, safe drug deactivation systems, medical and first aid supplies, and generic pharmaceuticals—not midecamycin specifically. The code shows a mismatch between its nominal scope and what state and local governments are actually buying under this classification. When present, purchases include emergency medical supplies (respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, bandaging materials, oxygen delivery systems), naloxone for community health initiatives, and multi-source generic pharmaceuticals distributed through authorized wholesalers to public health and safety agencies. Issuing bodies include county health departments, municipal fire departments, state health and human services agencies, and multistate cooperative purchasing alliances. The work spans procurement of finished medical goods and pharmaceuticals for distribution to public health, emergency response, and employee health benefit programs rather than raw pharmaceutical manufacturing inputs.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida released an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. The City of Tampa issued an IFB (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies totaling an estimated $700,000 for the Tampa Fire Department Rescue Division, with a 5 percent bid discount available to certified Small Local Business Enterprises. The Texas Health and Human Services Commission posted an RFI (HHS0017013, due April 3, 2026) seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products across participating state and local facilities, with awards effective July 1, 2026, and a 3 percent administrative fee requirement on all contract purchases.